Abstract | OBJECTIVE: PATIENTS AND METHODS: An observational study was carried out in 26 patients who were using gestodene 75 microg/ethinylestradiol 30 microg prior to endometrial resection. The patients were divided into two groups: those with amenorrhea (n = 14) and those who had irregular bleeding (n = 12). The resected endometrium was immunostained for COX-2, Bcl-2 and Ki-67 expression. Routine pathology was carried out using standard hematoxylin- eosin staining. RESULTS: Irregular bleeding during OC use was associated with strong COX-2 expression in both glandular and superficial epithelium. There were also more patients in this group with irregular endometrial maturation and higher Ki-67 values. Bcl-2 expression, on the other hand, was not affected by the presence of uterine bleeding. CONCLUSION: The presence of irregular bleeding during OC use is associated with strong COX-2 expression in the endometrium, thereby suggesting a pivotal role of prostaglandins in this process.
|
Authors | Hugo Maia, Tânia Correia, Luis Freitas, Célia Athayde, Elsimar M Coutinho |
Journal | Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
(Gynecol Endocrinol)
Vol. 22
Issue 2
Pg. 96-100
(Feb 2006)
ISSN: 0951-3590 [Print] England |
PMID | 16603435
(Publication Type: Journal Article)
|
Chemical References |
- Contraceptives, Oral
- Ki-67 Antigen
- Proto-Oncogene Proteins c-bcl-2
- Cyclooxygenase 2
|
Topics |
- Adult
- Contraceptives, Oral
(adverse effects)
- Cyclooxygenase 2
(analysis)
- Endometrium
(enzymology)
- Epithelium
(enzymology)
- Female
- Humans
- Ki-67 Antigen
(analysis)
- Middle Aged
- Proto-Oncogene Proteins c-bcl-2
(analysis)
- Uterine Hemorrhage
(chemically induced, enzymology)
|